Value of Biomarkers in the Prevention of Rheumatoid Arthritis. Issue 4 (19th July 2017)

• Record Type: Journal Article
• Authors: Finckh, A; Alpizar‐Rodriguez, D; Roux‐Lombard, P
• Is Part Of: Clinical pharmacology & therapeutics. Volume 102:Issue 4(2017)
• Page Start: 585
• Page End: 587
• Publication Date: 2017-07-19
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1002/cpt.727
• Languages: English
• ISSNs: 0009-9236

Abstract

Abstract : Recent diagnostic advances allow to identify persons in a pre‐symptomatic stage of rheumatoid arthritis (RA), opening the way for a preventive therapeutic intervention, which may potentially be curative. We review and discuss existing biomarkers predictive of future onset of RA. A responsible use of biomarkers in clinical settings will require an integration of blood‐based tests, imaging techniques, clinical history, environmental risk factors, and family history.